What details must be recorded on copy 3 of the DEA 222 Form?

Prepare for the New Jersey MPJE with engaging quizzes and study materials. Benefit from a comprehensive set of questions with detailed explanations for each answer. Enhance your understanding of state-specific pharmacy law to ensure success on exam day!

Multiple Choice

What details must be recorded on copy 3 of the DEA 222 Form?

Explanation:
The details that must be recorded on copy 3 of the DEA 222 Form include the number of containers received and the date they were received. This part of the form is essential for maintaining an accurate inventory and tracking the movement of controlled substances. Accurate record-keeping is a crucial element of compliance with the Drug Enforcement Administration (DEA) regulations. When a pharmacy or another entity receives controlled substances, they must document these details to ensure accountability and traceability. This information helps to confirm that the ordered quantities match what was actually received, and it aids in future audits or inspections by the DEA. Recording just the name of the drug, the signature of the registrant, or the return address of the supplier does not provide the necessary tracking details required on copy 3 of the DEA 222 Form, making those options insufficient for compliance purposes.

The details that must be recorded on copy 3 of the DEA 222 Form include the number of containers received and the date they were received. This part of the form is essential for maintaining an accurate inventory and tracking the movement of controlled substances. Accurate record-keeping is a crucial element of compliance with the Drug Enforcement Administration (DEA) regulations.

When a pharmacy or another entity receives controlled substances, they must document these details to ensure accountability and traceability. This information helps to confirm that the ordered quantities match what was actually received, and it aids in future audits or inspections by the DEA.

Recording just the name of the drug, the signature of the registrant, or the return address of the supplier does not provide the necessary tracking details required on copy 3 of the DEA 222 Form, making those options insufficient for compliance purposes.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy